Carrato Mena, Alfredo

Actividades

Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study

  • Abad, A.
  • Massutí, B.
  • Antón, A.
  • Vega, Ma.E.
  • Yuste, A.L.
  • Marcuello, E.
  • Manzano, J.L.
  • Alonso, V.
  • Carrato, A.
  • Martinez-Villacampa, M.
  • Tabernero, J.
  • Aranda, E.
  • Rivera, F.
  • Díaz-Rubio, E.
... Ver más Contraer

Acta Oncologica (p. 286-292) - 2008

10.1080/02841860701630259 Ver en origen

  • ISSN/ISBN 0284-186X

A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (Caplri-RT) as neoadjuvant treatment of locally advanced rectal cancer: Commentary

  • Montenegro-Beltrán, P.
  • Carrato, A.

Advances in Gastrointestinal Cancers (p. 20-21) - 2007

  • ISSN/ISBN 1479-9995

Don't lose perspective: The whole scenario counts

  • Carrato, A.

Advances in Gastrointestinal Cancers (p. 1-2) - 2008

  • ISSN/ISBN 1479-9995

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial: Commentary

  • Carrato, A.
  • Guillén-Ponce, C.

Advances in Gastrointestinal Cancers (p. 19-20) - 2007

  • ISSN/ISBN 1479-9995

The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer

  • Guillén-Ponce, C.
  • Carrato, A.

Advances in Gastrointestinal Cancers (p. 15-16) - 2009

  • ISSN/ISBN 1479-9995

Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: A trial of the Eastern Cooperative Oncology Group

  • Guillén-Ponce, C.
  • Carrato, A.

Advances in Gastrointestinal Cancers (p. 13-14) - 2009

  • ISSN/ISBN 1479-9995

Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer

  • Carrato, A.
  • Guillen-Ponce, C.

Advances in Gastrointestinal Cancers (p. 12-13) - 2007

  • ISSN/ISBN 1479-9995

A phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer

  • Carrato, A.
  • Guillén-Ponce, C.

Advances in Gastrointestinal Cancers (p. 14) - 2008

  • ISSN/ISBN 1479-9995

Anti-angiogenic agents in colorectal cancer

  • Guillén-Ponce, C.
  • Carrato, A.

Advances in Gastrointestinal Cancers (p. 7-12) - 2008

  • ISSN/ISBN 1479-9995

Single-agent irinotecan as second-line weekly chemotherapy in elderly patients with advanced colorectal cancer: Commentary

  • Carrato, A.

Advances in Gastrointestinal Cancers (p. 15) - 2007

  • ISSN/ISBN 1479-9995

Consenso sobre el manejo de factores de crecimiento

  • Alfredo Carrato Mena
  • Luis Paz-Ares Rodríguez
  • Álvaro Rodríguez Lescure

2006

Editor: Prodrug Multimedia

  • ISSN/ISBN 84-95972-35-2

Guía para el diagnóstico y tratamiento del cáncer de páncreas

  • Alfredo Carrato Mena (dir.)
  • Manuel Hidalgo Medina (dir.)

2017

Editor: Grupo Luzán 5

  • ISSN/ISBN 978-84-7989-846-5

Chemotherapy for Nonresectable Pancreatic Cancer

  • Fuentes, R.
  • Serrano, J.J.
  • Rodríguez, M.
  • Carrato, A.

Clinical Pancreatology for Practising Gastroenterologists and Surgeons: Second Edition (p. 530-537) - 2021

Editor: wiley

10.1002/9781119570097.ch65 Ver en origen

  • ISSN/ISBN 9781119570073

La investigación de resultados en salud : de la incertidumbre a la toma de decisiones

  • Laura Barreales Tolosa
  • Alfredo Carrato Mena

La gestión sanitaria orientada hacia la calidad y seguridad de los pacientes (p. 127-138) - 2017

Editor: Fundación MAPFRE

  • ISSN/ISBN 978-84-9844-633-3

Adjuvant therapy of resected gastric cancer is necessary

  • Carrato, A.
  • Gallego-Plazas, J.
  • Guillen-Ponce, C.

Seminars in Oncology (p. 105-108) - 2005

Editor: W.B. Saunders

10.1053/j.seminoncol.2005.06.005 Ver en origen

  • ISSN/ISBN 0093-7754

Este/a investigador/a no tiene documentos de trabajo.

Este/a investigador/a no tiene informes técnicos.

Este/a investigador/a no tiene proyectos de investigación.

Este/a investigador/a no tiene tesis dirigidas.

Este/a investigador/a no tiene patentes o licencias de software.

Última actualización de los datos: 24/04/24 13:18